Global Oncology Radiopharmaceutical Supply, Demand and Key Producers, 2023-2029
The global Oncology Radiopharmaceutical market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Oncology Radiopharmaceutical production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oncology Radiopharmaceutical, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncology Radiopharmaceutical that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oncology Radiopharmaceutical total production and demand, 2018-2029, (K Units)
Global Oncology Radiopharmaceutical total production value, 2018-2029, (USD Million)
Global Oncology Radiopharmaceutical production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oncology Radiopharmaceutical consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Oncology Radiopharmaceutical domestic production, consumption, key domestic manufacturers and share
Global Oncology Radiopharmaceutical production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Oncology Radiopharmaceutical production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oncology Radiopharmaceutical production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Oncology Radiopharmaceutical market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical lmaging, Inc., NanoMab, NuView Life Sciences., PentixaPharm GmbHPrecirix, RadioMedix and RayzeBio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oncology Radiopharmaceutical market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Oncology Radiopharmaceutical Market, By Region:
1. How big is the global Oncology Radiopharmaceutical market?
2. What is the demand of the global Oncology Radiopharmaceutical market?
3. What is the year over year growth of the global Oncology Radiopharmaceutical market?
4. What is the production and production value of the global Oncology Radiopharmaceutical market?
5. Who are the key producers in the global Oncology Radiopharmaceutical market?
6. What are the growth factors driving the market demand?
This report studies the global Oncology Radiopharmaceutical production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oncology Radiopharmaceutical, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncology Radiopharmaceutical that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oncology Radiopharmaceutical total production and demand, 2018-2029, (K Units)
Global Oncology Radiopharmaceutical total production value, 2018-2029, (USD Million)
Global Oncology Radiopharmaceutical production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oncology Radiopharmaceutical consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Oncology Radiopharmaceutical domestic production, consumption, key domestic manufacturers and share
Global Oncology Radiopharmaceutical production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Oncology Radiopharmaceutical production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oncology Radiopharmaceutical production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Oncology Radiopharmaceutical market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical lmaging, Inc., NanoMab, NuView Life Sciences., PentixaPharm GmbHPrecirix, RadioMedix and RayzeBio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oncology Radiopharmaceutical market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Oncology Radiopharmaceutical Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Oral Drugs
- Intravenous Drugs
- Other
- Hospitals and Clinics
- Pharmaceutical Company
- Research Center
- Other
- Novartis
- Chimeric Therapeutics Limited
- Fusion Pharma
- Lantheus Medical lmaging, Inc.
- NanoMab
- NuView Life Sciences.
- PentixaPharm GmbHPrecirix
- RadioMedix
- RayzeBio
- Telix Pharmaceuticals Limited
- Theragnostics Ltd
- Vect-Horus
1. How big is the global Oncology Radiopharmaceutical market?
2. What is the demand of the global Oncology Radiopharmaceutical market?
3. What is the year over year growth of the global Oncology Radiopharmaceutical market?
4. What is the production and production value of the global Oncology Radiopharmaceutical market?
5. Who are the key producers in the global Oncology Radiopharmaceutical market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Oncology Radiopharmaceutical Introduction
1.2 World Oncology Radiopharmaceutical Supply & Forecast
1.2.1 World Oncology Radiopharmaceutical Production Value (2018 & 2022 & 2029)
1.2.2 World Oncology Radiopharmaceutical Production (2018-2029)
1.2.3 World Oncology Radiopharmaceutical Pricing Trends (2018-2029)
1.3 World Oncology Radiopharmaceutical Production by Region (Based on Production Site)
1.3.1 World Oncology Radiopharmaceutical Production Value by Region (2018-2029)
1.3.2 World Oncology Radiopharmaceutical Production by Region (2018-2029)
1.3.3 World Oncology Radiopharmaceutical Average Price by Region (2018-2029)
1.3.4 North America Oncology Radiopharmaceutical Production (2018-2029)
1.3.5 Europe Oncology Radiopharmaceutical Production (2018-2029)
1.3.6 China Oncology Radiopharmaceutical Production (2018-2029)
1.3.7 Japan Oncology Radiopharmaceutical Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oncology Radiopharmaceutical Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oncology Radiopharmaceutical Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Oncology Radiopharmaceutical Demand (2018-2029)
2.2 World Oncology Radiopharmaceutical Consumption by Region
2.2.1 World Oncology Radiopharmaceutical Consumption by Region (2018-2023)
2.2.2 World Oncology Radiopharmaceutical Consumption Forecast by Region (2024-2029)
2.3 United States Oncology Radiopharmaceutical Consumption (2018-2029)
2.4 China Oncology Radiopharmaceutical Consumption (2018-2029)
2.5 Europe Oncology Radiopharmaceutical Consumption (2018-2029)
2.6 Japan Oncology Radiopharmaceutical Consumption (2018-2029)
2.7 South Korea Oncology Radiopharmaceutical Consumption (2018-2029)
2.8 ASEAN Oncology Radiopharmaceutical Consumption (2018-2029)
2.9 India Oncology Radiopharmaceutical Consumption (2018-2029)
3 WORLD ONCOLOGY RADIOPHARMACEUTICAL MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oncology Radiopharmaceutical Production Value by Manufacturer (2018-2023)
3.2 World Oncology Radiopharmaceutical Production by Manufacturer (2018-2023)
3.3 World Oncology Radiopharmaceutical Average Price by Manufacturer (2018-2023)
3.4 Oncology Radiopharmaceutical Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oncology Radiopharmaceutical Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oncology Radiopharmaceutical in 2022
3.5.3 Global Concentration Ratios (CR8) for Oncology Radiopharmaceutical in 2022
3.6 Oncology Radiopharmaceutical Market: Overall Company Footprint Analysis
3.6.1 Oncology Radiopharmaceutical Market: Region Footprint
3.6.2 Oncology Radiopharmaceutical Market: Company Product Type Footprint
3.6.3 Oncology Radiopharmaceutical Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oncology Radiopharmaceutical Production Value Comparison
4.1.1 United States VS China: Oncology Radiopharmaceutical Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Oncology Radiopharmaceutical Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Oncology Radiopharmaceutical Production Comparison
4.2.1 United States VS China: Oncology Radiopharmaceutical Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Oncology Radiopharmaceutical Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Oncology Radiopharmaceutical Consumption Comparison
4.3.1 United States VS China: Oncology Radiopharmaceutical Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Oncology Radiopharmaceutical Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Oncology Radiopharmaceutical Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Oncology Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oncology Radiopharmaceutical Production Value (2018-2023)
4.4.3 United States Based Manufacturers Oncology Radiopharmaceutical Production (2018-2023)
4.5 China Based Oncology Radiopharmaceutical Manufacturers and Market Share
4.5.1 China Based Oncology Radiopharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oncology Radiopharmaceutical Production Value (2018-2023)
4.5.3 China Based Manufacturers Oncology Radiopharmaceutical Production (2018-2023)
4.6 Rest of World Based Oncology Radiopharmaceutical Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Oncology Radiopharmaceutical Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oncology Radiopharmaceutical Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Oncology Radiopharmaceutical Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Oncology Radiopharmaceutical Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral Drugs
5.2.2 Intravenous Drugs
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Oncology Radiopharmaceutical Production by Type (2018-2029)
5.3.2 World Oncology Radiopharmaceutical Production Value by Type (2018-2029)
5.3.3 World Oncology Radiopharmaceutical Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oncology Radiopharmaceutical Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals and Clinics
6.2.2 Pharmaceutical Company
6.2.3 Research Center
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Oncology Radiopharmaceutical Production by Application (2018-2029)
6.3.2 World Oncology Radiopharmaceutical Production Value by Application (2018-2029)
6.3.3 World Oncology Radiopharmaceutical Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Oncology Radiopharmaceutical Product and Services
7.1.4 Novartis Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Chimeric Therapeutics Limited
7.2.1 Chimeric Therapeutics Limited Details
7.2.2 Chimeric Therapeutics Limited Major Business
7.2.3 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product and Services
7.2.4 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Chimeric Therapeutics Limited Recent Developments/Updates
7.2.6 Chimeric Therapeutics Limited Competitive Strengths & Weaknesses
7.3 Fusion Pharma
7.3.1 Fusion Pharma Details
7.3.2 Fusion Pharma Major Business
7.3.3 Fusion Pharma Oncology Radiopharmaceutical Product and Services
7.3.4 Fusion Pharma Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Fusion Pharma Recent Developments/Updates
7.3.6 Fusion Pharma Competitive Strengths & Weaknesses
7.4 Lantheus Medical lmaging, Inc.
7.4.1 Lantheus Medical lmaging, Inc. Details
7.4.2 Lantheus Medical lmaging, Inc. Major Business
7.4.3 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product and Services
7.4.4 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Lantheus Medical lmaging, Inc. Recent Developments/Updates
7.4.6 Lantheus Medical lmaging, Inc. Competitive Strengths & Weaknesses
7.5 NanoMab
7.5.1 NanoMab Details
7.5.2 NanoMab Major Business
7.5.3 NanoMab Oncology Radiopharmaceutical Product and Services
7.5.4 NanoMab Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 NanoMab Recent Developments/Updates
7.5.6 NanoMab Competitive Strengths & Weaknesses
7.6 NuView Life Sciences.
7.6.1 NuView Life Sciences. Details
7.6.2 NuView Life Sciences. Major Business
7.6.3 NuView Life Sciences. Oncology Radiopharmaceutical Product and Services
7.6.4 NuView Life Sciences. Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 NuView Life Sciences. Recent Developments/Updates
7.6.6 NuView Life Sciences. Competitive Strengths & Weaknesses
7.7 PentixaPharm GmbHPrecirix
7.7.1 PentixaPharm GmbHPrecirix Details
7.7.2 PentixaPharm GmbHPrecirix Major Business
7.7.3 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product and Services
7.7.4 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 PentixaPharm GmbHPrecirix Recent Developments/Updates
7.7.6 PentixaPharm GmbHPrecirix Competitive Strengths & Weaknesses
7.8 RadioMedix
7.8.1 RadioMedix Details
7.8.2 RadioMedix Major Business
7.8.3 RadioMedix Oncology Radiopharmaceutical Product and Services
7.8.4 RadioMedix Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 RadioMedix Recent Developments/Updates
7.8.6 RadioMedix Competitive Strengths & Weaknesses
7.9 RayzeBio
7.9.1 RayzeBio Details
7.9.2 RayzeBio Major Business
7.9.3 RayzeBio Oncology Radiopharmaceutical Product and Services
7.9.4 RayzeBio Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 RayzeBio Recent Developments/Updates
7.9.6 RayzeBio Competitive Strengths & Weaknesses
7.10 Telix Pharmaceuticals Limited
7.10.1 Telix Pharmaceuticals Limited Details
7.10.2 Telix Pharmaceuticals Limited Major Business
7.10.3 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product and Services
7.10.4 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Telix Pharmaceuticals Limited Recent Developments/Updates
7.10.6 Telix Pharmaceuticals Limited Competitive Strengths & Weaknesses
7.11 Theragnostics Ltd
7.11.1 Theragnostics Ltd Details
7.11.2 Theragnostics Ltd Major Business
7.11.3 Theragnostics Ltd Oncology Radiopharmaceutical Product and Services
7.11.4 Theragnostics Ltd Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Theragnostics Ltd Recent Developments/Updates
7.11.6 Theragnostics Ltd Competitive Strengths & Weaknesses
7.12 Vect-Horus
7.12.1 Vect-Horus Details
7.12.2 Vect-Horus Major Business
7.12.3 Vect-Horus Oncology Radiopharmaceutical Product and Services
7.12.4 Vect-Horus Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Vect-Horus Recent Developments/Updates
7.12.6 Vect-Horus Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oncology Radiopharmaceutical Industry Chain
8.2 Oncology Radiopharmaceutical Upstream Analysis
8.2.1 Oncology Radiopharmaceutical Core Raw Materials
8.2.2 Main Manufacturers of Oncology Radiopharmaceutical Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Oncology Radiopharmaceutical Production Mode
8.6 Oncology Radiopharmaceutical Procurement Model
8.7 Oncology Radiopharmaceutical Industry Sales Model and Sales Channels
8.7.1 Oncology Radiopharmaceutical Sales Model
8.7.2 Oncology Radiopharmaceutical Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Oncology Radiopharmaceutical Introduction
1.2 World Oncology Radiopharmaceutical Supply & Forecast
1.2.1 World Oncology Radiopharmaceutical Production Value (2018 & 2022 & 2029)
1.2.2 World Oncology Radiopharmaceutical Production (2018-2029)
1.2.3 World Oncology Radiopharmaceutical Pricing Trends (2018-2029)
1.3 World Oncology Radiopharmaceutical Production by Region (Based on Production Site)
1.3.1 World Oncology Radiopharmaceutical Production Value by Region (2018-2029)
1.3.2 World Oncology Radiopharmaceutical Production by Region (2018-2029)
1.3.3 World Oncology Radiopharmaceutical Average Price by Region (2018-2029)
1.3.4 North America Oncology Radiopharmaceutical Production (2018-2029)
1.3.5 Europe Oncology Radiopharmaceutical Production (2018-2029)
1.3.6 China Oncology Radiopharmaceutical Production (2018-2029)
1.3.7 Japan Oncology Radiopharmaceutical Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oncology Radiopharmaceutical Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oncology Radiopharmaceutical Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Oncology Radiopharmaceutical Demand (2018-2029)
2.2 World Oncology Radiopharmaceutical Consumption by Region
2.2.1 World Oncology Radiopharmaceutical Consumption by Region (2018-2023)
2.2.2 World Oncology Radiopharmaceutical Consumption Forecast by Region (2024-2029)
2.3 United States Oncology Radiopharmaceutical Consumption (2018-2029)
2.4 China Oncology Radiopharmaceutical Consumption (2018-2029)
2.5 Europe Oncology Radiopharmaceutical Consumption (2018-2029)
2.6 Japan Oncology Radiopharmaceutical Consumption (2018-2029)
2.7 South Korea Oncology Radiopharmaceutical Consumption (2018-2029)
2.8 ASEAN Oncology Radiopharmaceutical Consumption (2018-2029)
2.9 India Oncology Radiopharmaceutical Consumption (2018-2029)
3 WORLD ONCOLOGY RADIOPHARMACEUTICAL MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oncology Radiopharmaceutical Production Value by Manufacturer (2018-2023)
3.2 World Oncology Radiopharmaceutical Production by Manufacturer (2018-2023)
3.3 World Oncology Radiopharmaceutical Average Price by Manufacturer (2018-2023)
3.4 Oncology Radiopharmaceutical Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oncology Radiopharmaceutical Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oncology Radiopharmaceutical in 2022
3.5.3 Global Concentration Ratios (CR8) for Oncology Radiopharmaceutical in 2022
3.6 Oncology Radiopharmaceutical Market: Overall Company Footprint Analysis
3.6.1 Oncology Radiopharmaceutical Market: Region Footprint
3.6.2 Oncology Radiopharmaceutical Market: Company Product Type Footprint
3.6.3 Oncology Radiopharmaceutical Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oncology Radiopharmaceutical Production Value Comparison
4.1.1 United States VS China: Oncology Radiopharmaceutical Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Oncology Radiopharmaceutical Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Oncology Radiopharmaceutical Production Comparison
4.2.1 United States VS China: Oncology Radiopharmaceutical Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Oncology Radiopharmaceutical Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Oncology Radiopharmaceutical Consumption Comparison
4.3.1 United States VS China: Oncology Radiopharmaceutical Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Oncology Radiopharmaceutical Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Oncology Radiopharmaceutical Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Oncology Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oncology Radiopharmaceutical Production Value (2018-2023)
4.4.3 United States Based Manufacturers Oncology Radiopharmaceutical Production (2018-2023)
4.5 China Based Oncology Radiopharmaceutical Manufacturers and Market Share
4.5.1 China Based Oncology Radiopharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oncology Radiopharmaceutical Production Value (2018-2023)
4.5.3 China Based Manufacturers Oncology Radiopharmaceutical Production (2018-2023)
4.6 Rest of World Based Oncology Radiopharmaceutical Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Oncology Radiopharmaceutical Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oncology Radiopharmaceutical Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Oncology Radiopharmaceutical Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Oncology Radiopharmaceutical Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral Drugs
5.2.2 Intravenous Drugs
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Oncology Radiopharmaceutical Production by Type (2018-2029)
5.3.2 World Oncology Radiopharmaceutical Production Value by Type (2018-2029)
5.3.3 World Oncology Radiopharmaceutical Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oncology Radiopharmaceutical Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals and Clinics
6.2.2 Pharmaceutical Company
6.2.3 Research Center
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Oncology Radiopharmaceutical Production by Application (2018-2029)
6.3.2 World Oncology Radiopharmaceutical Production Value by Application (2018-2029)
6.3.3 World Oncology Radiopharmaceutical Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Oncology Radiopharmaceutical Product and Services
7.1.4 Novartis Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Chimeric Therapeutics Limited
7.2.1 Chimeric Therapeutics Limited Details
7.2.2 Chimeric Therapeutics Limited Major Business
7.2.3 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product and Services
7.2.4 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Chimeric Therapeutics Limited Recent Developments/Updates
7.2.6 Chimeric Therapeutics Limited Competitive Strengths & Weaknesses
7.3 Fusion Pharma
7.3.1 Fusion Pharma Details
7.3.2 Fusion Pharma Major Business
7.3.3 Fusion Pharma Oncology Radiopharmaceutical Product and Services
7.3.4 Fusion Pharma Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Fusion Pharma Recent Developments/Updates
7.3.6 Fusion Pharma Competitive Strengths & Weaknesses
7.4 Lantheus Medical lmaging, Inc.
7.4.1 Lantheus Medical lmaging, Inc. Details
7.4.2 Lantheus Medical lmaging, Inc. Major Business
7.4.3 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product and Services
7.4.4 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Lantheus Medical lmaging, Inc. Recent Developments/Updates
7.4.6 Lantheus Medical lmaging, Inc. Competitive Strengths & Weaknesses
7.5 NanoMab
7.5.1 NanoMab Details
7.5.2 NanoMab Major Business
7.5.3 NanoMab Oncology Radiopharmaceutical Product and Services
7.5.4 NanoMab Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 NanoMab Recent Developments/Updates
7.5.6 NanoMab Competitive Strengths & Weaknesses
7.6 NuView Life Sciences.
7.6.1 NuView Life Sciences. Details
7.6.2 NuView Life Sciences. Major Business
7.6.3 NuView Life Sciences. Oncology Radiopharmaceutical Product and Services
7.6.4 NuView Life Sciences. Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 NuView Life Sciences. Recent Developments/Updates
7.6.6 NuView Life Sciences. Competitive Strengths & Weaknesses
7.7 PentixaPharm GmbHPrecirix
7.7.1 PentixaPharm GmbHPrecirix Details
7.7.2 PentixaPharm GmbHPrecirix Major Business
7.7.3 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product and Services
7.7.4 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 PentixaPharm GmbHPrecirix Recent Developments/Updates
7.7.6 PentixaPharm GmbHPrecirix Competitive Strengths & Weaknesses
7.8 RadioMedix
7.8.1 RadioMedix Details
7.8.2 RadioMedix Major Business
7.8.3 RadioMedix Oncology Radiopharmaceutical Product and Services
7.8.4 RadioMedix Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 RadioMedix Recent Developments/Updates
7.8.6 RadioMedix Competitive Strengths & Weaknesses
7.9 RayzeBio
7.9.1 RayzeBio Details
7.9.2 RayzeBio Major Business
7.9.3 RayzeBio Oncology Radiopharmaceutical Product and Services
7.9.4 RayzeBio Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 RayzeBio Recent Developments/Updates
7.9.6 RayzeBio Competitive Strengths & Weaknesses
7.10 Telix Pharmaceuticals Limited
7.10.1 Telix Pharmaceuticals Limited Details
7.10.2 Telix Pharmaceuticals Limited Major Business
7.10.3 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product and Services
7.10.4 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Telix Pharmaceuticals Limited Recent Developments/Updates
7.10.6 Telix Pharmaceuticals Limited Competitive Strengths & Weaknesses
7.11 Theragnostics Ltd
7.11.1 Theragnostics Ltd Details
7.11.2 Theragnostics Ltd Major Business
7.11.3 Theragnostics Ltd Oncology Radiopharmaceutical Product and Services
7.11.4 Theragnostics Ltd Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Theragnostics Ltd Recent Developments/Updates
7.11.6 Theragnostics Ltd Competitive Strengths & Weaknesses
7.12 Vect-Horus
7.12.1 Vect-Horus Details
7.12.2 Vect-Horus Major Business
7.12.3 Vect-Horus Oncology Radiopharmaceutical Product and Services
7.12.4 Vect-Horus Oncology Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Vect-Horus Recent Developments/Updates
7.12.6 Vect-Horus Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oncology Radiopharmaceutical Industry Chain
8.2 Oncology Radiopharmaceutical Upstream Analysis
8.2.1 Oncology Radiopharmaceutical Core Raw Materials
8.2.2 Main Manufacturers of Oncology Radiopharmaceutical Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Oncology Radiopharmaceutical Production Mode
8.6 Oncology Radiopharmaceutical Procurement Model
8.7 Oncology Radiopharmaceutical Industry Sales Model and Sales Channels
8.7.1 Oncology Radiopharmaceutical Sales Model
8.7.2 Oncology Radiopharmaceutical Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Oncology Radiopharmaceutical Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Oncology Radiopharmaceutical Production Value by Region (2018-2023) & (USD Million)
Table 3. World Oncology Radiopharmaceutical Production Value by Region (2024-2029) & (USD Million)
Table 4. World Oncology Radiopharmaceutical Production Value Market Share by Region (2018-2023)
Table 5. World Oncology Radiopharmaceutical Production Value Market Share by Region (2024-2029)
Table 6. World Oncology Radiopharmaceutical Production by Region (2018-2023) & (K Units)
Table 7. World Oncology Radiopharmaceutical Production by Region (2024-2029) & (K Units)
Table 8. World Oncology Radiopharmaceutical Production Market Share by Region (2018-2023)
Table 9. World Oncology Radiopharmaceutical Production Market Share by Region (2024-2029)
Table 10. World Oncology Radiopharmaceutical Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Oncology Radiopharmaceutical Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Oncology Radiopharmaceutical Major Market Trends
Table 13. World Oncology Radiopharmaceutical Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Oncology Radiopharmaceutical Consumption by Region (2018-2023) & (K Units)
Table 15. World Oncology Radiopharmaceutical Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Oncology Radiopharmaceutical Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Oncology Radiopharmaceutical Producers in 2022
Table 18. World Oncology Radiopharmaceutical Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Oncology Radiopharmaceutical Producers in 2022
Table 20. World Oncology Radiopharmaceutical Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Oncology Radiopharmaceutical Company Evaluation Quadrant
Table 22. World Oncology Radiopharmaceutical Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Oncology Radiopharmaceutical Production Site of Key Manufacturer
Table 24. Oncology Radiopharmaceutical Market: Company Product Type Footprint
Table 25. Oncology Radiopharmaceutical Market: Company Product Application Footprint
Table 26. Oncology Radiopharmaceutical Competitive Factors
Table 27. Oncology Radiopharmaceutical New Entrant and Capacity Expansion Plans
Table 28. Oncology Radiopharmaceutical Mergers & Acquisitions Activity
Table 29. United States VS China Oncology Radiopharmaceutical Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Oncology Radiopharmaceutical Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Oncology Radiopharmaceutical Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Oncology Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oncology Radiopharmaceutical Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Oncology Radiopharmaceutical Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Oncology Radiopharmaceutical Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Oncology Radiopharmaceutical Production Market Share (2018-2023)
Table 37. China Based Oncology Radiopharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oncology Radiopharmaceutical Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Oncology Radiopharmaceutical Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Oncology Radiopharmaceutical Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Oncology Radiopharmaceutical Production Market Share (2018-2023)
Table 42. Rest of World Based Oncology Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Oncology Radiopharmaceutical Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Oncology Radiopharmaceutical Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Oncology Radiopharmaceutical Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Oncology Radiopharmaceutical Production Market Share (2018-2023)
Table 47. World Oncology Radiopharmaceutical Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Oncology Radiopharmaceutical Production by Type (2018-2023) & (K Units)
Table 49. World Oncology Radiopharmaceutical Production by Type (2024-2029) & (K Units)
Table 50. World Oncology Radiopharmaceutical Production Value by Type (2018-2023) & (USD Million)
Table 51. World Oncology Radiopharmaceutical Production Value by Type (2024-2029) & (USD Million)
Table 52. World Oncology Radiopharmaceutical Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Oncology Radiopharmaceutical Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Oncology Radiopharmaceutical Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Oncology Radiopharmaceutical Production by Application (2018-2023) & (K Units)
Table 56. World Oncology Radiopharmaceutical Production by Application (2024-2029) & (K Units)
Table 57. World Oncology Radiopharmaceutical Production Value by Application (2018-2023) & (USD Million)
Table 58. World Oncology Radiopharmaceutical Production Value by Application (2024-2029) & (USD Million)
Table 59. World Oncology Radiopharmaceutical Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Oncology Radiopharmaceutical Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Oncology Radiopharmaceutical Product and Services
Table 64. Novartis Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Chimeric Therapeutics Limited Basic Information, Manufacturing Base and Competitors
Table 68. Chimeric Therapeutics Limited Major Business
Table 69. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product and Services
Table 70. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Chimeric Therapeutics Limited Recent Developments/Updates
Table 72. Chimeric Therapeutics Limited Competitive Strengths & Weaknesses
Table 73. Fusion Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Fusion Pharma Major Business
Table 75. Fusion Pharma Oncology Radiopharmaceutical Product and Services
Table 76. Fusion Pharma Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Fusion Pharma Recent Developments/Updates
Table 78. Fusion Pharma Competitive Strengths & Weaknesses
Table 79. Lantheus Medical lmaging, Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Lantheus Medical lmaging, Inc. Major Business
Table 81. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product and Services
Table 82. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Lantheus Medical lmaging, Inc. Recent Developments/Updates
Table 84. Lantheus Medical lmaging, Inc. Competitive Strengths & Weaknesses
Table 85. NanoMab Basic Information, Manufacturing Base and Competitors
Table 86. NanoMab Major Business
Table 87. NanoMab Oncology Radiopharmaceutical Product and Services
Table 88. NanoMab Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. NanoMab Recent Developments/Updates
Table 90. NanoMab Competitive Strengths & Weaknesses
Table 91. NuView Life Sciences. Basic Information, Manufacturing Base and Competitors
Table 92. NuView Life Sciences. Major Business
Table 93. NuView Life Sciences. Oncology Radiopharmaceutical Product and Services
Table 94. NuView Life Sciences. Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. NuView Life Sciences. Recent Developments/Updates
Table 96. NuView Life Sciences. Competitive Strengths & Weaknesses
Table 97. PentixaPharm GmbHPrecirix Basic Information, Manufacturing Base and Competitors
Table 98. PentixaPharm GmbHPrecirix Major Business
Table 99. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product and Services
Table 100. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. PentixaPharm GmbHPrecirix Recent Developments/Updates
Table 102. PentixaPharm GmbHPrecirix Competitive Strengths & Weaknesses
Table 103. RadioMedix Basic Information, Manufacturing Base and Competitors
Table 104. RadioMedix Major Business
Table 105. RadioMedix Oncology Radiopharmaceutical Product and Services
Table 106. RadioMedix Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. RadioMedix Recent Developments/Updates
Table 108. RadioMedix Competitive Strengths & Weaknesses
Table 109. RayzeBio Basic Information, Manufacturing Base and Competitors
Table 110. RayzeBio Major Business
Table 111. RayzeBio Oncology Radiopharmaceutical Product and Services
Table 112. RayzeBio Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. RayzeBio Recent Developments/Updates
Table 114. RayzeBio Competitive Strengths & Weaknesses
Table 115. Telix Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 116. Telix Pharmaceuticals Limited Major Business
Table 117. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product and Services
Table 118. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Telix Pharmaceuticals Limited Recent Developments/Updates
Table 120. Telix Pharmaceuticals Limited Competitive Strengths & Weaknesses
Table 121. Theragnostics Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Theragnostics Ltd Major Business
Table 123. Theragnostics Ltd Oncology Radiopharmaceutical Product and Services
Table 124. Theragnostics Ltd Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Theragnostics Ltd Recent Developments/Updates
Table 126. Vect-Horus Basic Information, Manufacturing Base and Competitors
Table 127. Vect-Horus Major Business
Table 128. Vect-Horus Oncology Radiopharmaceutical Product and Services
Table 129. Vect-Horus Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Oncology Radiopharmaceutical Upstream (Raw Materials)
Table 131. Oncology Radiopharmaceutical Typical Customers
Table 132. Oncology Radiopharmaceutical Typical Distributors
Table 1. World Oncology Radiopharmaceutical Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Oncology Radiopharmaceutical Production Value by Region (2018-2023) & (USD Million)
Table 3. World Oncology Radiopharmaceutical Production Value by Region (2024-2029) & (USD Million)
Table 4. World Oncology Radiopharmaceutical Production Value Market Share by Region (2018-2023)
Table 5. World Oncology Radiopharmaceutical Production Value Market Share by Region (2024-2029)
Table 6. World Oncology Radiopharmaceutical Production by Region (2018-2023) & (K Units)
Table 7. World Oncology Radiopharmaceutical Production by Region (2024-2029) & (K Units)
Table 8. World Oncology Radiopharmaceutical Production Market Share by Region (2018-2023)
Table 9. World Oncology Radiopharmaceutical Production Market Share by Region (2024-2029)
Table 10. World Oncology Radiopharmaceutical Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Oncology Radiopharmaceutical Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Oncology Radiopharmaceutical Major Market Trends
Table 13. World Oncology Radiopharmaceutical Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Oncology Radiopharmaceutical Consumption by Region (2018-2023) & (K Units)
Table 15. World Oncology Radiopharmaceutical Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Oncology Radiopharmaceutical Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Oncology Radiopharmaceutical Producers in 2022
Table 18. World Oncology Radiopharmaceutical Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Oncology Radiopharmaceutical Producers in 2022
Table 20. World Oncology Radiopharmaceutical Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Oncology Radiopharmaceutical Company Evaluation Quadrant
Table 22. World Oncology Radiopharmaceutical Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Oncology Radiopharmaceutical Production Site of Key Manufacturer
Table 24. Oncology Radiopharmaceutical Market: Company Product Type Footprint
Table 25. Oncology Radiopharmaceutical Market: Company Product Application Footprint
Table 26. Oncology Radiopharmaceutical Competitive Factors
Table 27. Oncology Radiopharmaceutical New Entrant and Capacity Expansion Plans
Table 28. Oncology Radiopharmaceutical Mergers & Acquisitions Activity
Table 29. United States VS China Oncology Radiopharmaceutical Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Oncology Radiopharmaceutical Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Oncology Radiopharmaceutical Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Oncology Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oncology Radiopharmaceutical Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Oncology Radiopharmaceutical Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Oncology Radiopharmaceutical Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Oncology Radiopharmaceutical Production Market Share (2018-2023)
Table 37. China Based Oncology Radiopharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oncology Radiopharmaceutical Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Oncology Radiopharmaceutical Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Oncology Radiopharmaceutical Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Oncology Radiopharmaceutical Production Market Share (2018-2023)
Table 42. Rest of World Based Oncology Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Oncology Radiopharmaceutical Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Oncology Radiopharmaceutical Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Oncology Radiopharmaceutical Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Oncology Radiopharmaceutical Production Market Share (2018-2023)
Table 47. World Oncology Radiopharmaceutical Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Oncology Radiopharmaceutical Production by Type (2018-2023) & (K Units)
Table 49. World Oncology Radiopharmaceutical Production by Type (2024-2029) & (K Units)
Table 50. World Oncology Radiopharmaceutical Production Value by Type (2018-2023) & (USD Million)
Table 51. World Oncology Radiopharmaceutical Production Value by Type (2024-2029) & (USD Million)
Table 52. World Oncology Radiopharmaceutical Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Oncology Radiopharmaceutical Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Oncology Radiopharmaceutical Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Oncology Radiopharmaceutical Production by Application (2018-2023) & (K Units)
Table 56. World Oncology Radiopharmaceutical Production by Application (2024-2029) & (K Units)
Table 57. World Oncology Radiopharmaceutical Production Value by Application (2018-2023) & (USD Million)
Table 58. World Oncology Radiopharmaceutical Production Value by Application (2024-2029) & (USD Million)
Table 59. World Oncology Radiopharmaceutical Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Oncology Radiopharmaceutical Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Oncology Radiopharmaceutical Product and Services
Table 64. Novartis Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Chimeric Therapeutics Limited Basic Information, Manufacturing Base and Competitors
Table 68. Chimeric Therapeutics Limited Major Business
Table 69. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product and Services
Table 70. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Chimeric Therapeutics Limited Recent Developments/Updates
Table 72. Chimeric Therapeutics Limited Competitive Strengths & Weaknesses
Table 73. Fusion Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Fusion Pharma Major Business
Table 75. Fusion Pharma Oncology Radiopharmaceutical Product and Services
Table 76. Fusion Pharma Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Fusion Pharma Recent Developments/Updates
Table 78. Fusion Pharma Competitive Strengths & Weaknesses
Table 79. Lantheus Medical lmaging, Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Lantheus Medical lmaging, Inc. Major Business
Table 81. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product and Services
Table 82. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Lantheus Medical lmaging, Inc. Recent Developments/Updates
Table 84. Lantheus Medical lmaging, Inc. Competitive Strengths & Weaknesses
Table 85. NanoMab Basic Information, Manufacturing Base and Competitors
Table 86. NanoMab Major Business
Table 87. NanoMab Oncology Radiopharmaceutical Product and Services
Table 88. NanoMab Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. NanoMab Recent Developments/Updates
Table 90. NanoMab Competitive Strengths & Weaknesses
Table 91. NuView Life Sciences. Basic Information, Manufacturing Base and Competitors
Table 92. NuView Life Sciences. Major Business
Table 93. NuView Life Sciences. Oncology Radiopharmaceutical Product and Services
Table 94. NuView Life Sciences. Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. NuView Life Sciences. Recent Developments/Updates
Table 96. NuView Life Sciences. Competitive Strengths & Weaknesses
Table 97. PentixaPharm GmbHPrecirix Basic Information, Manufacturing Base and Competitors
Table 98. PentixaPharm GmbHPrecirix Major Business
Table 99. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product and Services
Table 100. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. PentixaPharm GmbHPrecirix Recent Developments/Updates
Table 102. PentixaPharm GmbHPrecirix Competitive Strengths & Weaknesses
Table 103. RadioMedix Basic Information, Manufacturing Base and Competitors
Table 104. RadioMedix Major Business
Table 105. RadioMedix Oncology Radiopharmaceutical Product and Services
Table 106. RadioMedix Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. RadioMedix Recent Developments/Updates
Table 108. RadioMedix Competitive Strengths & Weaknesses
Table 109. RayzeBio Basic Information, Manufacturing Base and Competitors
Table 110. RayzeBio Major Business
Table 111. RayzeBio Oncology Radiopharmaceutical Product and Services
Table 112. RayzeBio Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. RayzeBio Recent Developments/Updates
Table 114. RayzeBio Competitive Strengths & Weaknesses
Table 115. Telix Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 116. Telix Pharmaceuticals Limited Major Business
Table 117. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product and Services
Table 118. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Telix Pharmaceuticals Limited Recent Developments/Updates
Table 120. Telix Pharmaceuticals Limited Competitive Strengths & Weaknesses
Table 121. Theragnostics Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Theragnostics Ltd Major Business
Table 123. Theragnostics Ltd Oncology Radiopharmaceutical Product and Services
Table 124. Theragnostics Ltd Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Theragnostics Ltd Recent Developments/Updates
Table 126. Vect-Horus Basic Information, Manufacturing Base and Competitors
Table 127. Vect-Horus Major Business
Table 128. Vect-Horus Oncology Radiopharmaceutical Product and Services
Table 129. Vect-Horus Oncology Radiopharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Oncology Radiopharmaceutical Upstream (Raw Materials)
Table 131. Oncology Radiopharmaceutical Typical Customers
Table 132. Oncology Radiopharmaceutical Typical Distributors
LIST OF FIGURES
Figure 1. Oncology Radiopharmaceutical Picture
Figure 2. World Oncology Radiopharmaceutical Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Oncology Radiopharmaceutical Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Oncology Radiopharmaceutical Production (2018-2029) & (K Units)
Figure 5. World Oncology Radiopharmaceutical Average Price (2018-2029) & (US$/Unit)
Figure 6. World Oncology Radiopharmaceutical Production Value Market Share by Region (2018-2029)
Figure 7. World Oncology Radiopharmaceutical Production Market Share by Region (2018-2029)
Figure 8. North America Oncology Radiopharmaceutical Production (2018-2029) & (K Units)
Figure 9. Europe Oncology Radiopharmaceutical Production (2018-2029) & (K Units)
Figure 10. China Oncology Radiopharmaceutical Production (2018-2029) & (K Units)
Figure 11. Japan Oncology Radiopharmaceutical Production (2018-2029) & (K Units)
Figure 12. Oncology Radiopharmaceutical Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 15. World Oncology Radiopharmaceutical Consumption Market Share by Region (2018-2029)
Figure 16. United States Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 17. China Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 18. Europe Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 19. Japan Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 20. South Korea Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 22. India Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Oncology Radiopharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oncology Radiopharmaceutical Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oncology Radiopharmaceutical Markets in 2022
Figure 26. United States VS China: Oncology Radiopharmaceutical Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Oncology Radiopharmaceutical Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Oncology Radiopharmaceutical Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Oncology Radiopharmaceutical Production Market Share 2022
Figure 30. China Based Manufacturers Oncology Radiopharmaceutical Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Oncology Radiopharmaceutical Production Market Share 2022
Figure 32. World Oncology Radiopharmaceutical Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Oncology Radiopharmaceutical Production Value Market Share by Type in 2022
Figure 34. Oral Drugs
Figure 35. Intravenous Drugs
Figure 36. Other
Figure 37. World Oncology Radiopharmaceutical Production Market Share by Type (2018-2029)
Figure 38. World Oncology Radiopharmaceutical Production Value Market Share by Type (2018-2029)
Figure 39. World Oncology Radiopharmaceutical Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Oncology Radiopharmaceutical Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Oncology Radiopharmaceutical Production Value Market Share by Application in 2022
Figure 42. Hospitals and Clinics
Figure 43. Pharmaceutical Company
Figure 44. Research Center
Figure 45. Other
Figure 46. World Oncology Radiopharmaceutical Production Market Share by Application (2018-2029)
Figure 47. World Oncology Radiopharmaceutical Production Value Market Share by Application (2018-2029)
Figure 48. World Oncology Radiopharmaceutical Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Oncology Radiopharmaceutical Industry Chain
Figure 50. Oncology Radiopharmaceutical Procurement Model
Figure 51. Oncology Radiopharmaceutical Sales Model
Figure 52. Oncology Radiopharmaceutical Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Oncology Radiopharmaceutical Picture
Figure 2. World Oncology Radiopharmaceutical Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Oncology Radiopharmaceutical Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Oncology Radiopharmaceutical Production (2018-2029) & (K Units)
Figure 5. World Oncology Radiopharmaceutical Average Price (2018-2029) & (US$/Unit)
Figure 6. World Oncology Radiopharmaceutical Production Value Market Share by Region (2018-2029)
Figure 7. World Oncology Radiopharmaceutical Production Market Share by Region (2018-2029)
Figure 8. North America Oncology Radiopharmaceutical Production (2018-2029) & (K Units)
Figure 9. Europe Oncology Radiopharmaceutical Production (2018-2029) & (K Units)
Figure 10. China Oncology Radiopharmaceutical Production (2018-2029) & (K Units)
Figure 11. Japan Oncology Radiopharmaceutical Production (2018-2029) & (K Units)
Figure 12. Oncology Radiopharmaceutical Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 15. World Oncology Radiopharmaceutical Consumption Market Share by Region (2018-2029)
Figure 16. United States Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 17. China Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 18. Europe Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 19. Japan Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 20. South Korea Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 22. India Oncology Radiopharmaceutical Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Oncology Radiopharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oncology Radiopharmaceutical Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oncology Radiopharmaceutical Markets in 2022
Figure 26. United States VS China: Oncology Radiopharmaceutical Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Oncology Radiopharmaceutical Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Oncology Radiopharmaceutical Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Oncology Radiopharmaceutical Production Market Share 2022
Figure 30. China Based Manufacturers Oncology Radiopharmaceutical Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Oncology Radiopharmaceutical Production Market Share 2022
Figure 32. World Oncology Radiopharmaceutical Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Oncology Radiopharmaceutical Production Value Market Share by Type in 2022
Figure 34. Oral Drugs
Figure 35. Intravenous Drugs
Figure 36. Other
Figure 37. World Oncology Radiopharmaceutical Production Market Share by Type (2018-2029)
Figure 38. World Oncology Radiopharmaceutical Production Value Market Share by Type (2018-2029)
Figure 39. World Oncology Radiopharmaceutical Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Oncology Radiopharmaceutical Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Oncology Radiopharmaceutical Production Value Market Share by Application in 2022
Figure 42. Hospitals and Clinics
Figure 43. Pharmaceutical Company
Figure 44. Research Center
Figure 45. Other
Figure 46. World Oncology Radiopharmaceutical Production Market Share by Application (2018-2029)
Figure 47. World Oncology Radiopharmaceutical Production Value Market Share by Application (2018-2029)
Figure 48. World Oncology Radiopharmaceutical Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Oncology Radiopharmaceutical Industry Chain
Figure 50. Oncology Radiopharmaceutical Procurement Model
Figure 51. Oncology Radiopharmaceutical Sales Model
Figure 52. Oncology Radiopharmaceutical Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
